Listen on NewsRamp PodcastsFollow us on Google News

Get your free copy of the News Marketing Bookhere

Blockchain Transaction Record


92% of Phase 1 Study Participants Achieved a Reduction in PTSD Symptoms Using the Resona Health PEMF Device, Pulsar XO

Phase 1 consisted of 21 participants (n=21) both male and female over a wide age group. At the beginning of the study, the participants completed the PTSD checklist PCL-5 which is widely used by the Veterans Administration (VA) for testing the effectiveness of various interventions.

Exclusively at Newsworthy.ai — Newsworthy registers every press release distributed through this service on the blockchain so that we can provide verification services and make features such as the self-hosting of press releases available to our customers. The blockchain provides an immutable record of the press releases issued by this service. Immutability gives readers the assurance that the news they are reading has not been altered from the source document that this service distributed. We have shifted the Source of Truth to the blockchain for added protection.

Moving the Source of Truth to the blockchain improves transparency and increases trust between organizations submitting news and readers.

Key Takeaways (TLDR)

  • Resona Health's ongoing research project shows promising results for using PEMF devices to relieve several ailments, including PTSD.
  • Resona Health's Pulsar XO device is an affordable alternative to expensive high-powered machines to generate PEMF waves.
  • The Pulsar XO offers various therapies, including PTSD, migraines, and weight loss, with ongoing home pilot studies available.
BlockchainDetails
Chainpolygon-main
Transaction ID0xd994b1074c16012265ab21cdd9ccfbec5f7633abd9a1d440b75732bfdb95ecc3
Contract Address0xA7086CbdD2FEfc3382B0F37fE3Ee16ddE05934D2
NWAI Digital Fingerprint360-df0a79280e8208ea24834e28e49bd043
Registration Timestamp2022-11-03T18:29:07+00:00

Other Recent Blockchain Registered News for Resona Health